Structural biology and therapeutic targeting of axon degeneration [ 1/1/2021 - 12/31/2025 ]

Research Grant

Brief description The molecular mechanisms underlying SARM1 (sterile alpha and TIR 1) function will be investigated, which will allow design of inhibitors of axon degeneration, which can be developed into therapeutic agents for neurodegenerative disease. Outcomes are not only anticipated to support excellence in basic research, but have potential of assisting health sectors and the economy, by reducing the burden of prevalent neurodegenerative diseases such as peripheral neuropathies and traumatic brain injury.

Funding Amount $1,512,250

Funding Scheme Investigator Grants

Chief Investigator Dr Thomas Ve

Notes Emerging Leadership 2